Log in
Understanding Clinical Trials
1,162 members204 posts

CAR-T Clinical Trial

I am a caregiver for my wife who has follicular lymphoma. In November 2011, at the age of 65, my wife was diagnosed with follicular lymphoma Stage 4, Grade 3A. She had 50% bone marrow involvement. She is one of the 20% of follicular lymphoma patients who progress rapidly after treatments. In 3 years she progressed after R-CHOP (6 cycles), bendamustine/rituximab (6 cycles), and Ibrutinib (12 months). Then she took Idelalisib/rituximab as her fourth treatment. It worked great for 14 months then a PET scan showed she progressed again. She is now in an NIH CAR-T trial NCT02659943 was infused on March 2, 2016. She has been in complete remission for 13 months. Current CAR-T clinical trial data shows that once a follicular lymphoma patient achieves a complete remission they stay in complete remission.

1 Reply

Hi wmay13241 thank you for sharing your story! So glad to hear the good news regarding your wife's condition.

1 like

You may also like...